Funding shortfall threatens accelerated Ebola vaccine development amid African outbreak

A rapidly expanding Ebola outbreak in Africa has spurred urgent efforts to create new vaccines, but the key organization leading this work is running out of money. The financial constraints could delay or derail the response to the growing public health threat.

EXPANDED:

The rapid escalation of the current outbreak has created an urgent window for vaccine innovation. Yet the principal agency coordinating this accelerated push is now confronting a severe budget deficit, which threatens to slow the pace of clinical trials and manufacturing